Search
for
Sort by
Research 31–60 of 1000+
- Sacituzumab tirumotecan (sac-TMT/MK-2870/SKB264): a novel antibody–drug conjugate in breast cancer
- Comparison of the pharmacoeconomic profiles of treatment regimens for field pattern actinic keratoses
- Micro-segmental analysis of the entry pathway and distribution of zolpidem in hair from different scalp regions after a single dose
- Effect of Rubbing on the Distribution of Topically Applied Drugs into the Hair Follicles
- Turmeric Essential Oil Constituents as Potential Drug Candidates: A Comprehensive Overview of Their Individual Bioactivities
- Enhanced ex vivo skin retention of bicalutamide using a nano-in-micro composite: Drug-loaded lipid vesicles in a dissolving microarray patch
- Niosomes as a propitious carrier for topical drug delivery
- Disappearance of Tramadol and THC-COOH in Hair After Discontinuation of Abuse. Two Different Profiles
- Moving Beyond Boundaries: Utilization of Longitudinal Exposure–Response Model for Bounded Outcome Score to Inform Decision Making in the Accelerated Drug Development Paradigm
- The brief overview, antivirus and anti-SARS-CoV-2 activity, quantitative methods, and pharmacokinetics of cepharanthine: a potential small-molecule drug against COVID-19
- Cepharanthine: a review of the antiviral potential of a Japanese-approved alopecia drug in COVID-19
- Three months extended-release microspheres prepared by multi-microchannel microfluidics in beagle dog models
- Simultaneous Target-Mediated Drug Disposition-Pharmacodynamic (TMDD-PD) Modeling of Finasteride and Dutasteride: Impact of Target Binding and Turnover on Non-linear Pharmacokinetics
- Smart hydrogel dressings for advanced wound healing: from biomaterial design to microenvironment modulation
- Repurposed Drugs: Current Trends in Drug Discovery
- Molecular Docking Studies and ADME-Tox Prediction of Phytocompounds from Lycopersicon esculentum mill. as a Drug Candidate for Alopecia Treatment
- Formulation and Evaluation of Niosomal Gel for Treatment of Acne
- 41949 Raman spectroscopy of alopecia drugs to assess their potential for laser-assisted drug delivery
- Metformin: an old medication of new fashion: evolving new molecular mechanisms and clinical implications in polycystic ovary syndrome
- Recent trends in nanocarrier formulations of actives beyond minoxidil and 5-α reductase inhibitors in androgenetic alopecia management: A systematic review
- Evaluating the safety profile of α-1 blockers, 5α-reductase inhibitors, and PDE5I for BPH: a disproportionality analysis of real-world adverse events based on FDA adverse event reporting system (FAERS)
- Understanding Microemulsions and Nanoemulsions in (Trans)Dermal Delivery
- Logic-based modeling and drug repurposing for the prediction of novel therapeutic targets and combination regimens against E2F1-driven melanoma progression
- Risks Associated with 5α-Reductase Inhibitor Use: Analysis of Adverse Drug Reactions Reported to EudraVigilance
- Nanostructured Drug Delivery Systems for Targeting 5-α-Reductase Inhibitors to the Hair Follicle
- Evaluation and Treatment of Gender Dysphoria to Prepare for Gender Confirmation Surgery
- Review of Drug Repositioning in Cancer Therapeutics
- 5α-Metabolism in Finasteride-Treated Subjects and Male Pseudohermaphrodites with Inherited 5α-Reductase Deficiency
- Real-world safety of Tepotinib: Insights from the Food and Drug Administration Adverse Event Reporting System
- Spironolactone: An Anti-androgenic and Anti-hypertensive Drug That May Provide Protection Against the Novel Coronavirus (SARS-CoV-2) Induced Acute Respiratory Distress Syndrome (ARDS) in COVID-19